Astellas Pharma US Inc. agreed to pay 100 million and Amgen Inc. agreed to pay 24.75 million to resolve allegations that they each violated the False Claims Act by illegally paying the Medicare copays for their own products, through purportedly independent foundations that the companies used as mere conduits.